Erin B. Kennedy

Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.

K. Owzar, M. Ratain, M. Edelman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.